Position in RZLT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,865,980
+$997,109 QoQ
Shares Held
611,797
+66.2% QoQ
Ownership
0.635%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RZLT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. RZLT ranks #151 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in RZLT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,865,980 | 611,797 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $868,871 | 368,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,825,133 | 938,844 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,492,424 | 1,904,131 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,981,811 | 1,028,211 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,337,790 | 1,089,345 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $181,113 | 37,343 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||